Investigational Drug Information for troriluzole
✉ Email this page to a colleague
What is the development status for investigational drug troriluzole?
troriluzole is an investigational drug.
There have been 8 clinical trials for troriluzole.
The most recent clinical trial was a Phase 3 trial, which was initiated on December 22nd 2020.
The most common disease conditions in clinical trials are Disease, Obsessive-Compulsive Disorder, and Compulsive Personality Disorder. The leading clinical trial sponsors are Biohaven Pharmaceuticals, Inc., Dana-Farber Cancer Institute, and Cognitive Research Corporation.
There are two US patents protecting this investigational drug and thirty-three international patents.
Summary for troriluzole
| US Patents | 2 |
| International Patents | 33 |
| US Patent Applications | 34 |
| WIPO Patent Applications | 10 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 3 (2020-12-22) |
| Vendors | 20 |
Recent Clinical Trials for troriluzole
| Title | Sponsor | Phase |
|---|---|---|
| Troriluzole or Placebo Plus Ipi Plus Nivo in Mel Brain Mets | Biohaven Pharmaceuticals, Inc. | Phase 2 |
| Troriluzole or Placebo Plus Ipi Plus Nivo in Mel Brain Mets | Dana-Farber Cancer Institute | Phase 2 |
| Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder | Biohaven Pharmaceuticals, Inc. | Phase 3 |
Clinical Trial Summary for troriluzole
Top disease conditions for troriluzole
Top clinical trial sponsors for troriluzole
US Patents for troriluzole
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| troriluzole | ⤷ Sign Up | Riluzole prodrugs and their use | Biohaven Therapeutics Ltd. (New Haven, CT) | ⤷ Sign Up |
| troriluzole | ⤷ Sign Up | Prodrugs of riluzole and their method of use | Biohaven Therapeutics Ltd. (New Haven, CT) | ⤷ Sign Up |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for troriluzole
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| troriluzole | Australia | AU2016226463 | 2035-03-03 | ⤷ Sign Up |
| troriluzole | Australia | AU2020233650 | 2035-03-03 | ⤷ Sign Up |
| troriluzole | Australia | AU2022202163 | 2035-03-03 | ⤷ Sign Up |
| troriluzole | Brazil | BR112017018832 | 2035-03-03 | ⤷ Sign Up |
| troriluzole | Canada | CA2978158 | 2035-03-03 | ⤷ Sign Up |
| troriluzole | China | CN107567438 | 2035-03-03 | ⤷ Sign Up |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
